Clinical trial testing topical cream plus influenza vaccine in progress

(NIH/National Institute of Allergy and Infectious Diseases) A Phase 1 clinical trial examining whether a topical cream can enhance the immune response conferred by a 'pre-pandemic' influenza vaccine is underway at Baylor College of Medicine, a Vaccine and Treatment Evaluation Unit (VTEU) funded by NIAID. Investigators are evaluating whether imiquimod cream, commonly used to treat genital warts and certain skin cancers, can boost the body's immune response to an H5N1 influenza vaccine. The trial is enrolling 50 healthy adults ages 18-50 years. (Source: EurekAlert! - Infectious and Emerging Diseases)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2MQhQHc